東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Cell Biology." ]

切換: 標籤 | MARC模式 | ISBD

Mechanisms of vascular defects in di...

Kartha, C. C.

FindBook

Google Book

Amazon

博客來

Mechanisms of vascular defects in diabetes mellitus

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Mechanisms of vascular defects in diabetes mellitus/ edited by C.C. Kartha, Surya Ramachandran, Radhakrishna M. Pillai.
其他作者:	Kartha, C. C.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	xviii, 579 p. :ill., digital ;24 cm.
內容註:	Section 1 Introduction -- The Global Burden Of Diabetes And Its Vascular Complications -- SECTION 2 Pathogenesis -- Genetic Basis For Increased Risk For Vascular Diseases In Diabetes -- Vascular Remodelling In Diabetes Mellitus -- Pathogenesis Of The Plaque Vulnerability In Diabetes Mellitus -- Endothelial Dysfunction In Diabetes -- Smooth Muscle Cells In Diabetes Mellitus -- Monocytes Factors In Pathogenesis Of Vascular Lesions In Diabetes -- Endothelial Progenitor Cell Dysfunction In The Pathogenesis Of Vascular Complications Of Diabetes -- Pathogenetic mechanisms in diabetic retinopathy: from molecules to cells to tissues -- Perspectives on the vascular pathogenesis of diabetic neuropathy -- SECTION 3 Molecular mechanisms -- The Renin - Angiotensin System And Diabetes -- Adipokines And Vascular Disease In Diabetes -- G-Proteins In Vascular Complications Of Diabetes -- Histone Deacetylases In Vascular Pathophysiology: Regulation By Vasoactive Peptides And Growth Factors -- Role of non-coding RNAs in vascular complications of diabetes mellitus -- SECTION 4 Hemostatic Factors -- Diabetes As A Prothrombotic State -- Mechanisms Of Hypercoagulation And Aberrant Clot Lyses In Type 2 Diabetes -- Platelet Dysfunction In Type-2 Diabetes Mellitus -- SECTION 5 Metabolic Factors -- Advanced Glycation End Products In Diabetic Complications -- Atherogenicdyslipoproteinemia In Type 2 Diabetes Mellitus -- Vascular Remodeling: Homocysteine And Diabetes -- SECTION 6 Pharmacological Therapies -- Mechanisms Of Action Of Drugs For Treating Endothelial Dysfunction In Diabetes Mellitus -- Beneficial Effects Of Inorganic Nitrate/Nitrite On Vascular Function And Blood Pressure In Diabetes -- Myeloperoxidase (MPO): Do We Need Inhibitors?.
Contained By:	Springer eBooks
標題:	Diabetic angiopathies. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-60324-7
ISBN:	9783319603247

Mechanisms of vascular defects in diabetes mellitus
Mechanisms of vascular defects in diabetes mellitus[electronic resource] /edited by C.C. Kartha, Surya Ramachandran, Radhakrishna M. Pillai. - Cham :Springer International Publishing :2017. - xviii, 579 p. :ill., digital ;24 cm. - Advances in biochemistry in health and disease ;v.17. - Advances in biochemistry in health and disease ;v.17..

Section 1 Introduction -- The Global Burden Of Diabetes And Its Vascular Complications -- SECTION 2 Pathogenesis -- Genetic Basis For Increased Risk For Vascular Diseases In Diabetes -- Vascular Remodelling In Diabetes Mellitus -- Pathogenesis Of The Plaque Vulnerability In Diabetes Mellitus -- Endothelial Dysfunction In Diabetes -- Smooth Muscle Cells In Diabetes Mellitus -- Monocytes Factors In Pathogenesis Of Vascular Lesions In Diabetes -- Endothelial Progenitor Cell Dysfunction In The Pathogenesis Of Vascular Complications Of Diabetes -- Pathogenetic mechanisms in diabetic retinopathy: from molecules to cells to tissues -- Perspectives on the vascular pathogenesis of diabetic neuropathy -- SECTION 3 Molecular mechanisms -- The Renin - Angiotensin System And Diabetes -- Adipokines And Vascular Disease In Diabetes -- G-Proteins In Vascular Complications Of Diabetes -- Histone Deacetylases In Vascular Pathophysiology: Regulation By Vasoactive Peptides And Growth Factors -- Role of non-coding RNAs in vascular complications of diabetes mellitus -- SECTION 4 Hemostatic Factors -- Diabetes As A Prothrombotic State -- Mechanisms Of Hypercoagulation And Aberrant Clot Lyses In Type 2 Diabetes -- Platelet Dysfunction In Type-2 Diabetes Mellitus -- SECTION 5 Metabolic Factors -- Advanced Glycation End Products In Diabetic Complications -- Atherogenicdyslipoproteinemia In Type 2 Diabetes Mellitus -- Vascular Remodeling: Homocysteine And Diabetes -- SECTION 6 Pharmacological Therapies -- Mechanisms Of Action Of Drugs For Treating Endothelial Dysfunction In Diabetes Mellitus -- Beneficial Effects Of Inorganic Nitrate/Nitrite On Vascular Function And Blood Pressure In Diabetes -- Myeloperoxidase (MPO): Do We Need Inhibitors?.

This book comprising 24 chapters is devoted to the mechanisms for the pathogenesis of the spectrum of vascular diseases in diabetes. Cellular events and molecular pathways that regulate the structure and function of both small and large arteries, the dysregulation in these vessels caused by hyperglycemia, oxidative stress, metabolic and haemostatic derangements secondary to diabetes, are discussed. Mechanisms of vascular remodelling and rupture of atherosclerotic plaques in diabetes are also covered. Several of the reviews also discuss therapeutic targets and drugs employed to reduce endothelial dysfunction and vascular inflammation in diabetes. All articles are authored by experts in their respective research fields. This compendium will be of interest to both basic scientists and clinicians in the pursuit of unravelling the molecular basis of vascular diseases and also to those who seek to identify targets for therapy of vascular complications of diabetes.

ISBN: 9783319603247

Standard No.: 10.1007/978-3-319-60324-7doiSubjects--Topical Terms:

752485
Diabetic angiopathies.

LC Class. No.: RC700.D5

Dewey Class. No.: 616.462

Mechanisms of vascular defects in diabetes mellitus
LDR:03773nmm a2200325 a 4500 001 2106010
003 DE-He213
005 20180312114940.0
006 m d
007 cr nn 008maaau
008 180417s2017 gw s 0 eng d
020 $a 9783319603247 $q (electronic bk.)
020 $a 9783319603230 $q (paper)
024 7 $a 10.1007/978-3-319-60324-7 $2 doi
035 $a 978-3-319-60324-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC700.D5
072 7 $a PSF $2 bicssc
072 7 $a SCI049000 $2 bisacsh
082 0 4 $a 616.462 $2 23
090 $a RC700.D5 $b M486 2017
245 0 0 $a Mechanisms of vascular defects in diabetes mellitus $h [electronic resource] / $c edited by C.C. Kartha, Surya Ramachandran, Radhakrishna M. Pillai.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xviii, 579 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in biochemistry in health and disease ; $v v.17
505 0 $a Section 1 Introduction -- The Global Burden Of Diabetes And Its Vascular Complications -- SECTION 2 Pathogenesis -- Genetic Basis For Increased Risk For Vascular Diseases In Diabetes -- Vascular Remodelling In Diabetes Mellitus -- Pathogenesis Of The Plaque Vulnerability In Diabetes Mellitus -- Endothelial Dysfunction In Diabetes -- Smooth Muscle Cells In Diabetes Mellitus -- Monocytes Factors In Pathogenesis Of Vascular Lesions In Diabetes -- Endothelial Progenitor Cell Dysfunction In The Pathogenesis Of Vascular Complications Of Diabetes -- Pathogenetic mechanisms in diabetic retinopathy: from molecules to cells to tissues -- Perspectives on the vascular pathogenesis of diabetic neuropathy -- SECTION 3 Molecular mechanisms -- The Renin - Angiotensin System And Diabetes -- Adipokines And Vascular Disease In Diabetes -- G-Proteins In Vascular Complications Of Diabetes -- Histone Deacetylases In Vascular Pathophysiology: Regulation By Vasoactive Peptides And Growth Factors -- Role of non-coding RNAs in vascular complications of diabetes mellitus -- SECTION 4 Hemostatic Factors -- Diabetes As A Prothrombotic State -- Mechanisms Of Hypercoagulation And Aberrant Clot Lyses In Type 2 Diabetes -- Platelet Dysfunction In Type-2 Diabetes Mellitus -- SECTION 5 Metabolic Factors -- Advanced Glycation End Products In Diabetic Complications -- Atherogenicdyslipoproteinemia In Type 2 Diabetes Mellitus -- Vascular Remodeling: Homocysteine And Diabetes -- SECTION 6 Pharmacological Therapies -- Mechanisms Of Action Of Drugs For Treating Endothelial Dysfunction In Diabetes Mellitus -- Beneficial Effects Of Inorganic Nitrate/Nitrite On Vascular Function And Blood Pressure In Diabetes -- Myeloperoxidase (MPO): Do We Need Inhibitors?.
520 $a This book comprising 24 chapters is devoted to the mechanisms for the pathogenesis of the spectrum of vascular diseases in diabetes. Cellular events and molecular pathways that regulate the structure and function of both small and large arteries, the dysregulation in these vessels caused by hyperglycemia, oxidative stress, metabolic and haemostatic derangements secondary to diabetes, are discussed. Mechanisms of vascular remodelling and rupture of atherosclerotic plaques in diabetes are also covered. Several of the reviews also discuss therapeutic targets and drugs employed to reduce endothelial dysfunction and vascular inflammation in diabetes. All articles are authored by experts in their respective research fields. This compendium will be of interest to both basic scientists and clinicians in the pursuit of unravelling the molecular basis of vascular diseases and also to those who seek to identify targets for therapy of vascular complications of diabetes.
650 0 $a Diabetic angiopathies. $3 752485
650 1 4 $a Life Sciences. $3 890838
650 2 4 $a Cell Biology. $3 892383
650 2 4 $a Diabetes. $3 544344
700 1 $a Kartha, C. C. $3 3251450
700 1 $a Ramachandran, Surya. $3 3251451
700 1 $a Pillai, Radhakrishna M. $3 3251452
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in biochemistry in health and disease ; $v v.17. $3 3251453
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-60324-7
950 $a Biomedical and Life Sciences (Springer-11642)